Intellectual property photography contract template

#Intellectual property photography contract template update

ItвЂ™s pretty much impossible to track every one of your images. With the world being online, itвЂ™s very likely that eventually one of my images would show up somewhere it wasnвЂ™t meant to be.

Now an image can appear online and spread around the world in seconds, all without your knowledge. In the past, having your image used or copied by others was confined to print, such as newspapers, magazines and books. It was the correct thing to do, and I got some money out of this too. TheyвЂ™d found my contact details in the images metadata and called me to request permission - and offered a fee for its usage. I was approached recently by a popular music magazine who wanted to use a photo in a feature. It can also bring in extra income through licensing or selling your rights. It can help you take legal action against anyone who uses your images without permission. Protecting your work can help you in many ways. Branding your work is great visually but with some basic photoshop it can be removed or just plain cropped out.Д¬asual image theft may be deterred by watermarking an image but if someone is determined to use it, they will. This is more important than the watermark. Labelling photos means that if they do go awry, all the original ownership data is there. For example, embedding data in your digital images files (known as metadata) or superimposing a watermark over your images. You can use these as proof of your rights if the worst should happen. If you create or hold rights to a work, itвЂ™s important to keep records and data trails. This means that thereвЂ™s no official register of copyright works. Unlike other intellectual property ( IP) rights, copyright is a free, automatic right. With content spanning multiple disciplines and genres and more of it being accessible online itвЂ™s critical to try and protect what is yours. Right now, we offer our clients photography and video services, and more recently weвЂ™ve introduced aerial and 360-degree work.

#Intellectual property photography contract template update

Alterola undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise.The move to digital production provides opportunities for creatives to share their work widely, but it is important to ensure you protect your work. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. A further list and description of risks and uncertainties associated with an investment in Alterola can be found in AlterolaвЂ™s filings with the U.S. Actual events could differ materially from those projected herein and depend on a number of factors, including (inter alia), the success of AlterolaвЂ™s research and development strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, and the potential acceptance of any future product that may (if ever) be approved by the appropriate regulatory authorities by consumer and medical professionals. Forward-looking statements involve risks and uncertainties. This news release contains forward-looking statements that reflect AlterolaвЂ™s current expectations regarding future events, including statements regarding financial performance, the timing of preclinical studies and clinical trials, the timing and outcomes of regulatory or intellectual property decisions, the relevance of AlterolaвЂ™s product candidates currently in development. If you would like more information about Alterola Biotech Inc., please visit our website or contact our Investor Relations Department at +353 or Regarding Forward Looking Statements pharmaceutical medicines made from cannabinoid, cannabinoid-like, and non-cannabinoid APIs and targeting European novel food approval of cannabinoid-based, cannabinoid-like and non-cannabinoid ingredients and products. Non-cannabinoid pharmaceutical active pharmaceutical ingredients (APIs). Tim Rogers, Executive Chairman of Alterola Biotech, commenting on the acquisition said, вЂњWe are excited at the opportunity to acquire these assets which we believe complement and augment our existing portfolio of cannabinoid and cannabinoid-like development candidates.вЂќДЄlterola is a UK based pharmaceutical company developing cannabinoid, cannabinoid-like, and Along with the technology platforms and associated intellectual property come relationships with universities and several renowned academics.